nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—SLC16A1—Methotrexate—multiple sclerosis	0.0958	0.194	CbGbCtD
Valproic Acid—CYP2A6—Prednisolone—multiple sclerosis	0.0564	0.114	CbGbCtD
Valproic Acid—SLC22A7—Methotrexate—multiple sclerosis	0.0471	0.0952	CbGbCtD
Valproic Acid—CYP2A6—Dexamethasone—multiple sclerosis	0.0333	0.0672	CbGbCtD
Valproic Acid—SLC22A8—Methotrexate—multiple sclerosis	0.0288	0.0581	CbGbCtD
Valproic Acid—CYP3A4—Fingolimod—multiple sclerosis	0.0273	0.0552	CbGbCtD
Valproic Acid—CYP2C19—Prednisone—multiple sclerosis	0.0221	0.0445	CbGbCtD
Valproic Acid—CYP2B6—Dexamethasone—multiple sclerosis	0.0217	0.0438	CbGbCtD
Valproic Acid—SLC22A6—Methotrexate—multiple sclerosis	0.02	0.0405	CbGbCtD
Valproic Acid—CYP3A4—Methylprednisolone—multiple sclerosis	0.0176	0.0355	CbGbCtD
Valproic Acid—CYP3A5—Dexamethasone—multiple sclerosis	0.0171	0.0345	CbGbCtD
Valproic Acid—CYP2C8—Dexamethasone—multiple sclerosis	0.0164	0.0331	CbGbCtD
Valproic Acid—CYP2C19—Dexamethasone—multiple sclerosis	0.0138	0.0278	CbGbCtD
Valproic Acid—CYP3A4—Triamcinolone—multiple sclerosis	0.0133	0.0269	CbGbCtD
Valproic Acid—CYP3A4—Mitoxantrone—multiple sclerosis	0.0128	0.0259	CbGbCtD
Valproic Acid—CYP2C9—Dexamethasone—multiple sclerosis	0.0114	0.0231	CbGbCtD
Valproic Acid—CYP3A4—Betamethasone—multiple sclerosis	0.0114	0.0231	CbGbCtD
Valproic Acid—CYP3A4—Prednisolone—multiple sclerosis	0.0113	0.0228	CbGbCtD
Valproic Acid—CYP3A4—Prednisone—multiple sclerosis	0.0107	0.0215	CbGbCtD
Valproic Acid—CYP3A4—Dexamethasone—multiple sclerosis	0.00665	0.0134	CbGbCtD
Valproic Acid—OGDH—retina—multiple sclerosis	0.00327	0.0421	CbGeAlD
Valproic Acid—ALDH5A1—brainstem—multiple sclerosis	0.00237	0.0306	CbGeAlD
Valproic Acid—OGDH—medulla oblongata—multiple sclerosis	0.00237	0.0305	CbGeAlD
Valproic Acid—OGDH—spinal cord—multiple sclerosis	0.00211	0.0272	CbGeAlD
Valproic Acid—ABAT—brainstem—multiple sclerosis	0.00203	0.0261	CbGeAlD
Valproic Acid—ABAT—retina—multiple sclerosis	0.00196	0.0252	CbGeAlD
Valproic Acid—HDAC9—midbrain—multiple sclerosis	0.00191	0.0245	CbGeAlD
Valproic Acid—ACADSB—medulla oblongata—multiple sclerosis	0.00188	0.0242	CbGeAlD
Valproic Acid—OGDH—nervous system—multiple sclerosis	0.00178	0.0229	CbGeAlD
Valproic Acid—ACADSB—midbrain—multiple sclerosis	0.00172	0.0221	CbGeAlD
Valproic Acid—OGDH—central nervous system—multiple sclerosis	0.00171	0.022	CbGeAlD
Valproic Acid—ACADSB—spinal cord—multiple sclerosis	0.00168	0.0216	CbGeAlD
Valproic Acid—OGDH—cerebellum—multiple sclerosis	0.00167	0.0215	CbGeAlD
Valproic Acid—ALDH5A1—medulla oblongata—multiple sclerosis	0.00166	0.0213	CbGeAlD
Valproic Acid—HDAC9—nervous system—multiple sclerosis	0.00157	0.0202	CbGeAlD
Valproic Acid—HDAC2—brainstem—multiple sclerosis	0.00153	0.0197	CbGeAlD
Valproic Acid—ALDH5A1—midbrain—multiple sclerosis	0.00151	0.0195	CbGeAlD
Valproic Acid—HDAC9—central nervous system—multiple sclerosis	0.00151	0.0194	CbGeAlD
Valproic Acid—ALDH5A1—spinal cord—multiple sclerosis	0.00148	0.019	CbGeAlD
Valproic Acid—HDAC2—retina—multiple sclerosis	0.00148	0.019	CbGeAlD
Valproic Acid—HDAC9—cerebellum—multiple sclerosis	0.00148	0.019	CbGeAlD
Valproic Acid—ABAT—medulla oblongata—multiple sclerosis	0.00142	0.0182	CbGeAlD
Valproic Acid—OGDH—brain—multiple sclerosis	0.00136	0.0175	CbGeAlD
Valproic Acid—ACADSB—cerebellum—multiple sclerosis	0.00133	0.0171	CbGeAlD
Valproic Acid—SLC16A1—retina—multiple sclerosis	0.00131	0.0169	CbGeAlD
Valproic Acid—ABAT—midbrain—multiple sclerosis	0.00129	0.0167	CbGeAlD
Valproic Acid—ABAT—spinal cord—multiple sclerosis	0.00126	0.0163	CbGeAlD
Valproic Acid—ALDH5A1—nervous system—multiple sclerosis	0.00124	0.016	CbGeAlD
Valproic Acid—HDAC9—brain—multiple sclerosis	0.0012	0.0154	CbGeAlD
Valproic Acid—ALDH5A1—central nervous system—multiple sclerosis	0.0012	0.0154	CbGeAlD
Valproic Acid—ALDH5A1—cerebellum—multiple sclerosis	0.00117	0.0151	CbGeAlD
Valproic Acid—ACADSB—brain—multiple sclerosis	0.00108	0.0139	CbGeAlD
Valproic Acid—HDAC2—medulla oblongata—multiple sclerosis	0.00107	0.0137	CbGeAlD
Valproic Acid—ABAT—nervous system—multiple sclerosis	0.00106	0.0137	CbGeAlD
Valproic Acid—ABAT—central nervous system—multiple sclerosis	0.00102	0.0132	CbGeAlD
Valproic Acid—ABAT—cerebellum—multiple sclerosis	0.001	0.0129	CbGeAlD
Valproic Acid—HDAC2—midbrain—multiple sclerosis	0.000975	0.0125	CbGeAlD
Valproic Acid—ALDH5A1—brain—multiple sclerosis	0.000951	0.0122	CbGeAlD
Valproic Acid—SLC16A1—medulla oblongata—multiple sclerosis	0.000948	0.0122	CbGeAlD
Valproic Acid—SLC16A1—midbrain—multiple sclerosis	0.000866	0.0111	CbGeAlD
Valproic Acid—SLC16A1—spinal cord—multiple sclerosis	0.000845	0.0109	CbGeAlD
Valproic Acid—ABAT—brain—multiple sclerosis	0.000813	0.0105	CbGeAlD
Valproic Acid—HDAC2—nervous system—multiple sclerosis	0.000802	0.0103	CbGeAlD
Valproic Acid—HDAC2—central nervous system—multiple sclerosis	0.000772	0.00993	CbGeAlD
Valproic Acid—HDAC2—cerebellum—multiple sclerosis	0.000754	0.00971	CbGeAlD
Valproic Acid—SLC22A5—retina—multiple sclerosis	0.000749	0.00964	CbGeAlD
Valproic Acid—SLC16A1—nervous system—multiple sclerosis	0.000712	0.00917	CbGeAlD
Valproic Acid—SLC22A7—brain—multiple sclerosis	0.000712	0.00916	CbGeAlD
Valproic Acid—SLC22A6—brain—multiple sclerosis	0.000687	0.00885	CbGeAlD
Valproic Acid—SLC16A1—central nervous system—multiple sclerosis	0.000686	0.00882	CbGeAlD
Valproic Acid—SLC16A1—cerebellum—multiple sclerosis	0.00067	0.00863	CbGeAlD
Valproic Acid—CYP2A6—cerebellum—multiple sclerosis	0.00066	0.0085	CbGeAlD
Valproic Acid—HDAC2—brain—multiple sclerosis	0.000613	0.00788	CbGeAlD
Valproic Acid—SLC16A1—brain—multiple sclerosis	0.000544	0.00701	CbGeAlD
Valproic Acid—SLC22A5—medulla oblongata—multiple sclerosis	0.000542	0.00697	CbGeAlD
Valproic Acid—SLC22A8—nervous system—multiple sclerosis	0.000538	0.00693	CbGeAlD
Valproic Acid—CYP2A6—brain—multiple sclerosis	0.000536	0.0069	CbGeAlD
Valproic Acid—SLC22A8—central nervous system—multiple sclerosis	0.000518	0.00667	CbGeAlD
Valproic Acid—SLC22A5—midbrain—multiple sclerosis	0.000495	0.00637	CbGeAlD
Valproic Acid—SLC22A5—spinal cord—multiple sclerosis	0.000483	0.00622	CbGeAlD
Valproic Acid—SLC22A8—brain—multiple sclerosis	0.000412	0.0053	CbGeAlD
Valproic Acid—SLC22A5—cerebellum—multiple sclerosis	0.000383	0.00493	CbGeAlD
Valproic Acid—PTGS1—spinal cord—multiple sclerosis	0.000379	0.00488	CbGeAlD
Valproic Acid—CYP2B6—nervous system—multiple sclerosis	0.000353	0.00455	CbGeAlD
Valproic Acid—CYP2B6—central nervous system—multiple sclerosis	0.00034	0.00438	CbGeAlD
Valproic Acid—PTGS1—nervous system—multiple sclerosis	0.000319	0.00411	CbGeAlD
Valproic Acid—SLC22A5—brain—multiple sclerosis	0.000311	0.004	CbGeAlD
Valproic Acid—PTGS1—central nervous system—multiple sclerosis	0.000308	0.00396	CbGeAlD
Valproic Acid—CYP2C8—brain—multiple sclerosis	0.000301	0.00388	CbGeAlD
Valproic Acid—CYP2B6—brain—multiple sclerosis	0.00027	0.00348	CbGeAlD
Valproic Acid—CYP3A4—nervous system—multiple sclerosis	0.000267	0.00343	CbGeAlD
Valproic Acid—CYP3A4—central nervous system—multiple sclerosis	0.000257	0.00331	CbGeAlD
Valproic Acid—PTGS1—brain—multiple sclerosis	0.000244	0.00314	CbGeAlD
Valproic Acid—Sweating—Methotrexate—multiple sclerosis	0.000153	0.000541	CcSEcCtD
Valproic Acid—Infection—Methylprednisolone—multiple sclerosis	0.000152	0.00054	CcSEcCtD
Valproic Acid—Insomnia—Prednisolone—multiple sclerosis	0.000151	0.000536	CcSEcCtD
Valproic Acid—Alopecia—Prednisone—multiple sclerosis	0.000151	0.000535	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000151	0.000533	CcSEcCtD
Valproic Acid—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00015	0.000533	CcSEcCtD
Valproic Acid—Epistaxis—Methotrexate—multiple sclerosis	0.00015	0.000532	CcSEcCtD
Valproic Acid—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00015	0.000532	CcSEcCtD
Valproic Acid—Paraesthesia—Prednisolone—multiple sclerosis	0.00015	0.000532	CcSEcCtD
Valproic Acid—Tachycardia—Triamcinolone—multiple sclerosis	0.00015	0.000532	CcSEcCtD
Valproic Acid—Mental disorder—Prednisone—multiple sclerosis	0.00015	0.000531	CcSEcCtD
Valproic Acid—Nausea—Azathioprine—multiple sclerosis	0.00015	0.000531	CcSEcCtD
Valproic Acid—Tachycardia—Methylprednisolone—multiple sclerosis	0.00015	0.00053	CcSEcCtD
Valproic Acid—Skin disorder—Methylprednisolone—multiple sclerosis	0.000149	0.000528	CcSEcCtD
Valproic Acid—Malnutrition—Prednisone—multiple sclerosis	0.000149	0.000527	CcSEcCtD
Valproic Acid—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000149	0.000527	CcSEcCtD
Valproic Acid—Agranulocytosis—Methotrexate—multiple sclerosis	0.000149	0.000526	CcSEcCtD
Valproic Acid—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000148	0.000525	CcSEcCtD
Valproic Acid—Hypertension—Dexamethasone—multiple sclerosis	0.000148	0.000523	CcSEcCtD
Valproic Acid—Hypertension—Betamethasone—multiple sclerosis	0.000148	0.000523	CcSEcCtD
Valproic Acid—Asthenia—Mitoxantrone—multiple sclerosis	0.000146	0.000518	CcSEcCtD
Valproic Acid—Myalgia—Dexamethasone—multiple sclerosis	0.000146	0.000516	CcSEcCtD
Valproic Acid—Myalgia—Betamethasone—multiple sclerosis	0.000146	0.000516	CcSEcCtD
Valproic Acid—Anxiety—Dexamethasone—multiple sclerosis	0.000145	0.000514	CcSEcCtD
Valproic Acid—Anxiety—Betamethasone—multiple sclerosis	0.000145	0.000514	CcSEcCtD
Valproic Acid—Discomfort—Dexamethasone—multiple sclerosis	0.000144	0.000509	CcSEcCtD
Valproic Acid—Discomfort—Betamethasone—multiple sclerosis	0.000144	0.000509	CcSEcCtD
Valproic Acid—Haemoglobin—Methotrexate—multiple sclerosis	0.000144	0.000509	CcSEcCtD
Valproic Acid—Hypotension—Methylprednisolone—multiple sclerosis	0.000143	0.000508	CcSEcCtD
Valproic Acid—Pain—Prednisolone—multiple sclerosis	0.000143	0.000507	CcSEcCtD
Valproic Acid—Haemorrhage—Methotrexate—multiple sclerosis	0.000143	0.000506	CcSEcCtD
Valproic Acid—Pharyngitis—Methotrexate—multiple sclerosis	0.000142	0.000503	CcSEcCtD
Valproic Acid—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000141	0.0005	CcSEcCtD
Valproic Acid—Vision blurred—Prednisone—multiple sclerosis	0.00014	0.000497	CcSEcCtD
Valproic Acid—Urethral disorder—Methotrexate—multiple sclerosis	0.00014	0.000496	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00014	0.000496	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00014	0.000495	CcSEcCtD
Valproic Acid—Oedema—Betamethasone—multiple sclerosis	0.00014	0.000494	CcSEcCtD
Valproic Acid—Oedema—Dexamethasone—multiple sclerosis	0.00014	0.000494	CcSEcCtD
Valproic Acid—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00014	0.000494	CcSEcCtD
Valproic Acid—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00014	0.000494	CcSEcCtD
Valproic Acid—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000139	0.000494	CcSEcCtD
Valproic Acid—Insomnia—Triamcinolone—multiple sclerosis	0.000139	0.000493	CcSEcCtD
Valproic Acid—Insomnia—Methylprednisolone—multiple sclerosis	0.000139	0.000492	CcSEcCtD
Valproic Acid—Infection—Betamethasone—multiple sclerosis	0.000139	0.000491	CcSEcCtD
Valproic Acid—Infection—Dexamethasone—multiple sclerosis	0.000139	0.000491	CcSEcCtD
Valproic Acid—Ill-defined disorder—Prednisone—multiple sclerosis	0.000138	0.000489	CcSEcCtD
Valproic Acid—Paraesthesia—Triamcinolone—multiple sclerosis	0.000138	0.000489	CcSEcCtD
Valproic Acid—Feeling abnormal—Prednisolone—multiple sclerosis	0.000138	0.000488	CcSEcCtD
Valproic Acid—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000138	0.000488	CcSEcCtD
Valproic Acid—Visual impairment—Methotrexate—multiple sclerosis	0.000138	0.000488	CcSEcCtD
Valproic Acid—Anaemia—Prednisone—multiple sclerosis	0.000138	0.000487	CcSEcCtD
Valproic Acid—Dyspnoea—Triamcinolone—multiple sclerosis	0.000137	0.000486	CcSEcCtD
Valproic Acid—Nervous system disorder—Betamethasone—multiple sclerosis	0.000137	0.000485	CcSEcCtD
Valproic Acid—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000137	0.000485	CcSEcCtD
Valproic Acid—Agitation—Prednisone—multiple sclerosis	0.000137	0.000485	CcSEcCtD
Valproic Acid—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000137	0.000484	CcSEcCtD
Valproic Acid—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000137	0.000484	CcSEcCtD
Valproic Acid—Tachycardia—Betamethasone—multiple sclerosis	0.000136	0.000482	CcSEcCtD
Valproic Acid—Tachycardia—Dexamethasone—multiple sclerosis	0.000136	0.000482	CcSEcCtD
Valproic Acid—Angioedema—Prednisone—multiple sclerosis	0.000136	0.000482	CcSEcCtD
Valproic Acid—Dyspepsia—Triamcinolone—multiple sclerosis	0.000135	0.00048	CcSEcCtD
Valproic Acid—Erythema multiforme—Methotrexate—multiple sclerosis	0.000135	0.000479	CcSEcCtD
Valproic Acid—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000135	0.000478	CcSEcCtD
Valproic Acid—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000135	0.000478	CcSEcCtD
Valproic Acid—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000135	0.000478	CcSEcCtD
Valproic Acid—Malaise—Prednisone—multiple sclerosis	0.000134	0.000476	CcSEcCtD
Valproic Acid—Vertigo—Prednisone—multiple sclerosis	0.000134	0.000474	CcSEcCtD
Valproic Acid—Eye disorder—Methotrexate—multiple sclerosis	0.000134	0.000473	CcSEcCtD
Valproic Acid—Tinnitus—Methotrexate—multiple sclerosis	0.000133	0.000472	CcSEcCtD
Valproic Acid—Anorexia—Betamethasone—multiple sclerosis	0.000133	0.000471	CcSEcCtD
Valproic Acid—Anorexia—Dexamethasone—multiple sclerosis	0.000133	0.000471	CcSEcCtD
Valproic Acid—Urticaria—Prednisolone—multiple sclerosis	0.000133	0.000471	CcSEcCtD
Valproic Acid—Fatigue—Triamcinolone—multiple sclerosis	0.000133	0.00047	CcSEcCtD
Valproic Acid—Fatigue—Methylprednisolone—multiple sclerosis	0.000132	0.000469	CcSEcCtD
Valproic Acid—Pain—Triamcinolone—multiple sclerosis	0.000132	0.000466	CcSEcCtD
Valproic Acid—Hypotension—Dexamethasone—multiple sclerosis	0.00013	0.000462	CcSEcCtD
Valproic Acid—Hypotension—Betamethasone—multiple sclerosis	0.00013	0.000462	CcSEcCtD
Valproic Acid—Angiopathy—Methotrexate—multiple sclerosis	0.00013	0.000459	CcSEcCtD
Valproic Acid—Vomiting—Mitoxantrone—multiple sclerosis	0.00013	0.000459	CcSEcCtD
Valproic Acid—Immune system disorder—Methotrexate—multiple sclerosis	0.000129	0.000457	CcSEcCtD
Valproic Acid—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000129	0.000456	CcSEcCtD
Valproic Acid—Hypertension—Prednisone—multiple sclerosis	0.000129	0.000455	CcSEcCtD
Valproic Acid—Rash—Mitoxantrone—multiple sclerosis	0.000129	0.000455	CcSEcCtD
Valproic Acid—Dermatitis—Mitoxantrone—multiple sclerosis	0.000128	0.000455	CcSEcCtD
Valproic Acid—Chills—Methotrexate—multiple sclerosis	0.000128	0.000454	CcSEcCtD
Valproic Acid—Headache—Mitoxantrone—multiple sclerosis	0.000128	0.000452	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000127	0.00045	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000127	0.00045	CcSEcCtD
Valproic Acid—Myalgia—Prednisone—multiple sclerosis	0.000127	0.000449	CcSEcCtD
Valproic Acid—Arthralgia—Prednisone—multiple sclerosis	0.000127	0.000449	CcSEcCtD
Valproic Acid—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000127	0.000449	CcSEcCtD
Valproic Acid—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000126	0.000448	CcSEcCtD
Valproic Acid—Anxiety—Prednisone—multiple sclerosis	0.000126	0.000447	CcSEcCtD
Valproic Acid—Alopecia—Methotrexate—multiple sclerosis	0.000126	0.000447	CcSEcCtD
Valproic Acid—Insomnia—Betamethasone—multiple sclerosis	0.000126	0.000447	CcSEcCtD
Valproic Acid—Insomnia—Dexamethasone—multiple sclerosis	0.000126	0.000447	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000126	0.000446	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000125	0.000444	CcSEcCtD
Valproic Acid—Paraesthesia—Dexamethasone—multiple sclerosis	0.000125	0.000444	CcSEcCtD
Valproic Acid—Paraesthesia—Betamethasone—multiple sclerosis	0.000125	0.000444	CcSEcCtD
Valproic Acid—Discomfort—Prednisone—multiple sclerosis	0.000125	0.000444	CcSEcCtD
Valproic Acid—Mental disorder—Methotrexate—multiple sclerosis	0.000125	0.000444	CcSEcCtD
Valproic Acid—Malnutrition—Methotrexate—multiple sclerosis	0.000124	0.000441	CcSEcCtD
Valproic Acid—Hypersensitivity—Prednisolone—multiple sclerosis	0.000123	0.000436	CcSEcCtD
Valproic Acid—Dyspepsia—Dexamethasone—multiple sclerosis	0.000123	0.000435	CcSEcCtD
Valproic Acid—Dyspepsia—Betamethasone—multiple sclerosis	0.000123	0.000435	CcSEcCtD
Valproic Acid—Urticaria—Triamcinolone—multiple sclerosis	0.000122	0.000433	CcSEcCtD
Valproic Acid—Urticaria—Methylprednisolone—multiple sclerosis	0.000122	0.000432	CcSEcCtD
Valproic Acid—Dysgeusia—Methotrexate—multiple sclerosis	0.000122	0.000432	CcSEcCtD
Valproic Acid—Body temperature increased—Triamcinolone—multiple sclerosis	0.000122	0.000431	CcSEcCtD
Valproic Acid—Anaphylactic shock—Prednisone—multiple sclerosis	0.000122	0.00043	CcSEcCtD
Valproic Acid—Oedema—Prednisone—multiple sclerosis	0.000122	0.00043	CcSEcCtD
Valproic Acid—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000121	0.00043	CcSEcCtD
Valproic Acid—Decreased appetite—Dexamethasone—multiple sclerosis	0.000121	0.00043	CcSEcCtD
Valproic Acid—Decreased appetite—Betamethasone—multiple sclerosis	0.000121	0.00043	CcSEcCtD
Valproic Acid—Nausea—Mitoxantrone—multiple sclerosis	0.000121	0.000429	CcSEcCtD
Valproic Acid—Infection—Prednisone—multiple sclerosis	0.000121	0.000428	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00012	0.000427	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00012	0.000427	CcSEcCtD
Valproic Acid—Back pain—Methotrexate—multiple sclerosis	0.00012	0.000426	CcSEcCtD
Valproic Acid—Fatigue—Betamethasone—multiple sclerosis	0.00012	0.000426	CcSEcCtD
Valproic Acid—Fatigue—Dexamethasone—multiple sclerosis	0.00012	0.000426	CcSEcCtD
Valproic Acid—Pain—Betamethasone—multiple sclerosis	0.000119	0.000423	CcSEcCtD
Valproic Acid—Pain—Dexamethasone—multiple sclerosis	0.000119	0.000423	CcSEcCtD
Valproic Acid—Nervous system disorder—Prednisone—multiple sclerosis	0.000119	0.000422	CcSEcCtD
Valproic Acid—Tachycardia—Prednisone—multiple sclerosis	0.000119	0.00042	CcSEcCtD
Valproic Acid—Skin disorder—Prednisone—multiple sclerosis	0.000118	0.000418	CcSEcCtD
Valproic Acid—Hyperhidrosis—Prednisone—multiple sclerosis	0.000117	0.000416	CcSEcCtD
Valproic Acid—Vision blurred—Methotrexate—multiple sclerosis	0.000117	0.000415	CcSEcCtD
Valproic Acid—Anorexia—Prednisone—multiple sclerosis	0.000116	0.00041	CcSEcCtD
Valproic Acid—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000115	0.000409	CcSEcCtD
Valproic Acid—Anaemia—Methotrexate—multiple sclerosis	0.000115	0.000407	CcSEcCtD
Valproic Acid—Feeling abnormal—Betamethasone—multiple sclerosis	0.000115	0.000407	CcSEcCtD
Valproic Acid—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000115	0.000407	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000114	0.000404	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000114	0.000404	CcSEcCtD
Valproic Acid—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000113	0.000401	CcSEcCtD
Valproic Acid—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000113	0.0004	CcSEcCtD
Valproic Acid—Malaise—Methotrexate—multiple sclerosis	0.000112	0.000397	CcSEcCtD
Valproic Acid—Vertigo—Methotrexate—multiple sclerosis	0.000112	0.000396	CcSEcCtD
Valproic Acid—Leukopenia—Methotrexate—multiple sclerosis	0.000111	0.000395	CcSEcCtD
Valproic Acid—Urticaria—Betamethasone—multiple sclerosis	0.000111	0.000393	CcSEcCtD
Valproic Acid—Urticaria—Dexamethasone—multiple sclerosis	0.000111	0.000393	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000111	0.000392	CcSEcCtD
Valproic Acid—Dizziness—Prednisolone—multiple sclerosis	0.000111	0.000392	CcSEcCtD
Valproic Acid—Asthenia—Triamcinolone—multiple sclerosis	0.00011	0.000391	CcSEcCtD
Valproic Acid—Body temperature increased—Dexamethasone—multiple sclerosis	0.00011	0.000391	CcSEcCtD
Valproic Acid—Body temperature increased—Betamethasone—multiple sclerosis	0.00011	0.000391	CcSEcCtD
Valproic Acid—Abdominal pain—Betamethasone—multiple sclerosis	0.00011	0.000391	CcSEcCtD
Valproic Acid—Abdominal pain—Dexamethasone—multiple sclerosis	0.00011	0.000391	CcSEcCtD
Valproic Acid—Asthenia—Methylprednisolone—multiple sclerosis	0.00011	0.00039	CcSEcCtD
Valproic Acid—Insomnia—Prednisone—multiple sclerosis	0.00011	0.000389	CcSEcCtD
Valproic Acid—Paraesthesia—Prednisone—multiple sclerosis	0.000109	0.000387	CcSEcCtD
Valproic Acid—Pruritus—Triamcinolone—multiple sclerosis	0.000109	0.000385	CcSEcCtD
Valproic Acid—Cough—Methotrexate—multiple sclerosis	0.000109	0.000385	CcSEcCtD
Valproic Acid—Pruritus—Methylprednisolone—multiple sclerosis	0.000109	0.000385	CcSEcCtD
Valproic Acid—Dyspepsia—Prednisone—multiple sclerosis	0.000107	0.000379	CcSEcCtD
Valproic Acid—Chest pain—Methotrexate—multiple sclerosis	0.000106	0.000375	CcSEcCtD
Valproic Acid—Myalgia—Methotrexate—multiple sclerosis	0.000106	0.000375	CcSEcCtD
Valproic Acid—Arthralgia—Methotrexate—multiple sclerosis	0.000106	0.000375	CcSEcCtD
Valproic Acid—Decreased appetite—Prednisone—multiple sclerosis	0.000106	0.000374	CcSEcCtD
Valproic Acid—Rash—Prednisolone—multiple sclerosis	0.000105	0.000373	CcSEcCtD
Valproic Acid—Dermatitis—Prednisolone—multiple sclerosis	0.000105	0.000373	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000105	0.000373	CcSEcCtD
Valproic Acid—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000105	0.000372	CcSEcCtD
Valproic Acid—Fatigue—Prednisone—multiple sclerosis	0.000105	0.000371	CcSEcCtD
Valproic Acid—Headache—Prednisolone—multiple sclerosis	0.000105	0.000371	CcSEcCtD
Valproic Acid—Discomfort—Methotrexate—multiple sclerosis	0.000105	0.000371	CcSEcCtD
Valproic Acid—Constipation—Prednisone—multiple sclerosis	0.000104	0.000368	CcSEcCtD
Valproic Acid—Confusional state—Methotrexate—multiple sclerosis	0.000102	0.000363	CcSEcCtD
Valproic Acid—Dizziness—Triamcinolone—multiple sclerosis	0.000102	0.00036	CcSEcCtD
Valproic Acid—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000102	0.00036	CcSEcCtD
Valproic Acid—Dizziness—Methylprednisolone—multiple sclerosis	0.000101	0.000359	CcSEcCtD
Valproic Acid—Infection—Methotrexate—multiple sclerosis	0.000101	0.000357	CcSEcCtD
Valproic Acid—Feeling abnormal—Prednisone—multiple sclerosis	0.0001	0.000355	CcSEcCtD
Valproic Acid—Asthenia—Dexamethasone—multiple sclerosis	0.0001	0.000355	CcSEcCtD
Valproic Acid—Asthenia—Betamethasone—multiple sclerosis	0.0001	0.000355	CcSEcCtD
Valproic Acid—Nervous system disorder—Methotrexate—multiple sclerosis	9.96e-05	0.000353	CcSEcCtD
Valproic Acid—Thrombocytopenia—Methotrexate—multiple sclerosis	9.94e-05	0.000352	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Prednisone—multiple sclerosis	9.94e-05	0.000352	CcSEcCtD
Valproic Acid—Nausea—Prednisolone—multiple sclerosis	9.93e-05	0.000352	CcSEcCtD
Valproic Acid—Pruritus—Dexamethasone—multiple sclerosis	9.87e-05	0.00035	CcSEcCtD
Valproic Acid—Pruritus—Betamethasone—multiple sclerosis	9.87e-05	0.00035	CcSEcCtD
Valproic Acid—Skin disorder—Methotrexate—multiple sclerosis	9.86e-05	0.000349	CcSEcCtD
Valproic Acid—Hyperhidrosis—Methotrexate—multiple sclerosis	9.82e-05	0.000348	CcSEcCtD
Valproic Acid—Vomiting—Triamcinolone—multiple sclerosis	9.78e-05	0.000346	CcSEcCtD
Valproic Acid—Vomiting—Methylprednisolone—multiple sclerosis	9.76e-05	0.000346	CcSEcCtD
Valproic Acid—Rash—Triamcinolone—multiple sclerosis	9.7e-05	0.000343	CcSEcCtD
Valproic Acid—Dermatitis—Triamcinolone—multiple sclerosis	9.69e-05	0.000343	CcSEcCtD
Valproic Acid—Anorexia—Methotrexate—multiple sclerosis	9.68e-05	0.000343	CcSEcCtD
Valproic Acid—Rash—Methylprednisolone—multiple sclerosis	9.68e-05	0.000343	CcSEcCtD
Valproic Acid—Dermatitis—Methylprednisolone—multiple sclerosis	9.67e-05	0.000342	CcSEcCtD
Valproic Acid—Urticaria—Prednisone—multiple sclerosis	9.65e-05	0.000342	CcSEcCtD
Valproic Acid—Headache—Triamcinolone—multiple sclerosis	9.63e-05	0.000341	CcSEcCtD
Valproic Acid—Headache—Methylprednisolone—multiple sclerosis	9.61e-05	0.000341	CcSEcCtD
Valproic Acid—Abdominal pain—Prednisone—multiple sclerosis	9.61e-05	0.00034	CcSEcCtD
Valproic Acid—Body temperature increased—Prednisone—multiple sclerosis	9.61e-05	0.00034	CcSEcCtD
Valproic Acid—Diarrhoea—Dexamethasone—multiple sclerosis	9.55e-05	0.000338	CcSEcCtD
Valproic Acid—Diarrhoea—Betamethasone—multiple sclerosis	9.55e-05	0.000338	CcSEcCtD
Valproic Acid—Hypotension—Methotrexate—multiple sclerosis	9.49e-05	0.000336	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9.25e-05	0.000328	CcSEcCtD
Valproic Acid—Dizziness—Betamethasone—multiple sclerosis	9.23e-05	0.000327	CcSEcCtD
Valproic Acid—Dizziness—Dexamethasone—multiple sclerosis	9.23e-05	0.000327	CcSEcCtD
Valproic Acid—Insomnia—Methotrexate—multiple sclerosis	9.19e-05	0.000325	CcSEcCtD
Valproic Acid—Nausea—Triamcinolone—multiple sclerosis	9.13e-05	0.000324	CcSEcCtD
Valproic Acid—Paraesthesia—Methotrexate—multiple sclerosis	9.12e-05	0.000323	CcSEcCtD
Valproic Acid—Nausea—Methylprednisolone—multiple sclerosis	9.11e-05	0.000323	CcSEcCtD
Valproic Acid—Dyspnoea—Methotrexate—multiple sclerosis	9.05e-05	0.000321	CcSEcCtD
Valproic Acid—Somnolence—Methotrexate—multiple sclerosis	9.03e-05	0.00032	CcSEcCtD
Valproic Acid—Hypersensitivity—Prednisone—multiple sclerosis	8.95e-05	0.000317	CcSEcCtD
Valproic Acid—Dyspepsia—Methotrexate—multiple sclerosis	8.94e-05	0.000317	CcSEcCtD
Valproic Acid—Vomiting—Dexamethasone—multiple sclerosis	8.87e-05	0.000314	CcSEcCtD
Valproic Acid—Vomiting—Betamethasone—multiple sclerosis	8.87e-05	0.000314	CcSEcCtD
Valproic Acid—Decreased appetite—Methotrexate—multiple sclerosis	8.83e-05	0.000313	CcSEcCtD
Valproic Acid—Rash—Dexamethasone—multiple sclerosis	8.8e-05	0.000312	CcSEcCtD
Valproic Acid—Rash—Betamethasone—multiple sclerosis	8.8e-05	0.000312	CcSEcCtD
Valproic Acid—Dermatitis—Betamethasone—multiple sclerosis	8.79e-05	0.000311	CcSEcCtD
Valproic Acid—Dermatitis—Dexamethasone—multiple sclerosis	8.79e-05	0.000311	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Methotrexate—multiple sclerosis	8.77e-05	0.000311	CcSEcCtD
Valproic Acid—Fatigue—Methotrexate—multiple sclerosis	8.76e-05	0.00031	CcSEcCtD
Valproic Acid—Headache—Dexamethasone—multiple sclerosis	8.74e-05	0.00031	CcSEcCtD
Valproic Acid—Headache—Betamethasone—multiple sclerosis	8.74e-05	0.00031	CcSEcCtD
Valproic Acid—Asthenia—Prednisone—multiple sclerosis	8.72e-05	0.000309	CcSEcCtD
Valproic Acid—Pain—Methotrexate—multiple sclerosis	8.68e-05	0.000308	CcSEcCtD
Valproic Acid—Pruritus—Prednisone—multiple sclerosis	8.6e-05	0.000305	CcSEcCtD
Valproic Acid—Feeling abnormal—Methotrexate—multiple sclerosis	8.37e-05	0.000296	CcSEcCtD
Valproic Acid—Diarrhoea—Prednisone—multiple sclerosis	8.31e-05	0.000295	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.3e-05	0.000294	CcSEcCtD
Valproic Acid—Nausea—Dexamethasone—multiple sclerosis	8.29e-05	0.000294	CcSEcCtD
Valproic Acid—Nausea—Betamethasone—multiple sclerosis	8.29e-05	0.000294	CcSEcCtD
Valproic Acid—Urticaria—Methotrexate—multiple sclerosis	8.07e-05	0.000286	CcSEcCtD
Valproic Acid—Dizziness—Prednisone—multiple sclerosis	8.04e-05	0.000285	CcSEcCtD
Valproic Acid—Abdominal pain—Methotrexate—multiple sclerosis	8.03e-05	0.000284	CcSEcCtD
Valproic Acid—Body temperature increased—Methotrexate—multiple sclerosis	8.03e-05	0.000284	CcSEcCtD
Valproic Acid—Vomiting—Prednisone—multiple sclerosis	7.73e-05	0.000274	CcSEcCtD
Valproic Acid—Rash—Prednisone—multiple sclerosis	7.66e-05	0.000271	CcSEcCtD
Valproic Acid—Dermatitis—Prednisone—multiple sclerosis	7.66e-05	0.000271	CcSEcCtD
Valproic Acid—Headache—Prednisone—multiple sclerosis	7.61e-05	0.00027	CcSEcCtD
Valproic Acid—Hypersensitivity—Methotrexate—multiple sclerosis	7.48e-05	0.000265	CcSEcCtD
Valproic Acid—Asthenia—Methotrexate—multiple sclerosis	7.29e-05	0.000258	CcSEcCtD
Valproic Acid—Nausea—Prednisone—multiple sclerosis	7.22e-05	0.000256	CcSEcCtD
Valproic Acid—Pruritus—Methotrexate—multiple sclerosis	7.19e-05	0.000255	CcSEcCtD
Valproic Acid—Diarrhoea—Methotrexate—multiple sclerosis	6.95e-05	0.000246	CcSEcCtD
Valproic Acid—Dizziness—Methotrexate—multiple sclerosis	6.72e-05	0.000238	CcSEcCtD
Valproic Acid—Vomiting—Methotrexate—multiple sclerosis	6.46e-05	0.000229	CcSEcCtD
Valproic Acid—Rash—Methotrexate—multiple sclerosis	6.4e-05	0.000227	CcSEcCtD
Valproic Acid—Dermatitis—Methotrexate—multiple sclerosis	6.4e-05	0.000227	CcSEcCtD
Valproic Acid—Headache—Methotrexate—multiple sclerosis	6.36e-05	0.000225	CcSEcCtD
Valproic Acid—Nausea—Methotrexate—multiple sclerosis	6.03e-05	0.000214	CcSEcCtD
Valproic Acid—HDAC2—Disease—SLC11A1—multiple sclerosis	5.01e-05	0.000345	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.99e-05	0.000344	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.99e-05	0.000344	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—RRM1—multiple sclerosis	4.97e-05	0.000343	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RGS1—multiple sclerosis	4.92e-05	0.000339	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—RRM1—multiple sclerosis	4.84e-05	0.000334	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CD80—multiple sclerosis	4.8e-05	0.000331	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GPC5—multiple sclerosis	4.74e-05	0.000327	CbGpPWpGaD
Valproic Acid—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.7e-05	0.000324	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GPR65—multiple sclerosis	4.66e-05	0.000322	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CD86—multiple sclerosis	4.61e-05	0.000318	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SRM—multiple sclerosis	4.58e-05	0.000316	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCL5—multiple sclerosis	4.53e-05	0.000313	CbGpPWpGaD
Valproic Acid—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.5e-05	0.00031	CbGpPWpGaD
Valproic Acid—UGT1A9—NRF2 pathway—TGFB1—multiple sclerosis	4.48e-05	0.000309	CbGpPWpGaD
Valproic Acid—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.48e-05	0.000309	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SRM—multiple sclerosis	4.47e-05	0.000309	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—PGR—multiple sclerosis	4.43e-05	0.000306	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL13—multiple sclerosis	4.27e-05	0.000294	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCR1—multiple sclerosis	4.27e-05	0.000294	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.26e-05	0.000294	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.26e-05	0.000294	CbGpPWpGaD
Valproic Acid—CYP2B6—Biological oxidations—POMC—multiple sclerosis	4.24e-05	0.000293	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP27B1—multiple sclerosis	4.23e-05	0.000292	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP24A1—multiple sclerosis	4.23e-05	0.000292	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SPP1—multiple sclerosis	4.2e-05	0.00029	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—APOE—multiple sclerosis	4.2e-05	0.00029	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.15e-05	0.000286	CbGpPWpGaD
Valproic Acid—CYP3A5—Biological oxidations—POMC—multiple sclerosis	4.15e-05	0.000286	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.14e-05	0.000285	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.13e-05	0.000285	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	4.13e-05	0.000285	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCR5—multiple sclerosis	4.09e-05	0.000282	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—ALB—multiple sclerosis	4.07e-05	0.000281	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.06e-05	0.00028	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TYK2—multiple sclerosis	4.05e-05	0.000279	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL2RA—multiple sclerosis	4.03e-05	0.000278	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—STAT3—multiple sclerosis	4.01e-05	0.000277	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CD28—multiple sclerosis	4e-05	0.000276	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	4e-05	0.000276	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	4e-05	0.000276	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—BCHE—multiple sclerosis	3.93e-05	0.000271	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—RRM1—multiple sclerosis	3.93e-05	0.000271	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SRM—multiple sclerosis	3.88e-05	0.000267	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GPC5—multiple sclerosis	3.87e-05	0.000267	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.86e-05	0.000266	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.86e-05	0.000266	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—ALB—multiple sclerosis	3.72e-05	0.000257	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—APOE—multiple sclerosis	3.72e-05	0.000256	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—IL6—multiple sclerosis	3.71e-05	0.000256	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—APOE—multiple sclerosis	3.67e-05	0.000253	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CD4—multiple sclerosis	3.66e-05	0.000253	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GPC5—multiple sclerosis	3.66e-05	0.000252	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—MAPK1—multiple sclerosis	3.65e-05	0.000251	CbGpPWpGaD
Valproic Acid—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.63e-05	0.00025	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—POMC—multiple sclerosis	3.61e-05	0.000249	CbGpPWpGaD
Valproic Acid—CYP2C8—Biological oxidations—POMC—multiple sclerosis	3.59e-05	0.000248	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.52e-05	0.000243	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—BCHE—multiple sclerosis	3.5e-05	0.000242	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SRM—multiple sclerosis	3.46e-05	0.000239	CbGpPWpGaD
Valproic Acid—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	3.46e-05	0.000238	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CD80—multiple sclerosis	3.36e-05	0.000232	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—IL2—multiple sclerosis	3.3e-05	0.000228	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—ALB—multiple sclerosis	3.29e-05	0.000227	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—BCHE—multiple sclerosis	3.27e-05	0.000225	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.26e-05	0.000225	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	3.23e-05	0.000222	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	3.23e-05	0.000222	CbGpPWpGaD
Valproic Acid—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.21e-05	0.000221	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—RRM1—multiple sclerosis	3.2e-05	0.000221	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—POMC—multiple sclerosis	3.19e-05	0.00022	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SRM—multiple sclerosis	3.15e-05	0.000218	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	3.15e-05	0.000217	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	3.15e-05	0.000217	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—POMC—multiple sclerosis	3.15e-05	0.000217	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCL2—multiple sclerosis	3.12e-05	0.000215	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—VDR—multiple sclerosis	3.1e-05	0.000214	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—APOE—multiple sclerosis	3.06e-05	0.000211	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.05e-05	0.00021	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCL3—multiple sclerosis	3.04e-05	0.00021	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.03e-05	0.000209	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—RRM1—multiple sclerosis	3.03e-05	0.000209	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—IL2—multiple sclerosis	3.02e-05	0.000208	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GPC5—multiple sclerosis	2.95e-05	0.000203	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTGER4—multiple sclerosis	2.93e-05	0.000202	CbGpPWpGaD
Valproic Acid—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.92e-05	0.000202	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.88e-05	0.000199	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PGR—multiple sclerosis	2.88e-05	0.000199	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—ALB—multiple sclerosis	2.87e-05	0.000198	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—BCHE—multiple sclerosis	2.86e-05	0.000197	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CD86—multiple sclerosis	2.85e-05	0.000197	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TYK2—multiple sclerosis	2.84e-05	0.000196	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—STAT3—multiple sclerosis	2.84e-05	0.000196	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCR3—multiple sclerosis	2.83e-05	0.000195	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—IL6—multiple sclerosis	2.8e-05	0.000193	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CD28—multiple sclerosis	2.8e-05	0.000193	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—BCHE—multiple sclerosis	2.78e-05	0.000192	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCR2—multiple sclerosis	2.75e-05	0.00019	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.74e-05	0.000189	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.73e-05	0.000188	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.73e-05	0.000188	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SRM—multiple sclerosis	2.7e-05	0.000186	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.67e-05	0.000184	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MYC—multiple sclerosis	2.64e-05	0.000182	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—POMC—multiple sclerosis	2.63e-05	0.000181	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TGFB1—multiple sclerosis	2.63e-05	0.000181	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.62e-05	0.000181	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MAPK1—multiple sclerosis	2.58e-05	0.000178	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TGFB1—multiple sclerosis	2.57e-05	0.000178	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CNR1—multiple sclerosis	2.54e-05	0.000175	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CCR5—multiple sclerosis	2.53e-05	0.000174	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—MAPK1—multiple sclerosis	2.52e-05	0.000174	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.5e-05	0.000172	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.5e-05	0.000172	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.49e-05	0.000171	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HLA-A—multiple sclerosis	2.47e-05	0.00017	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—RRM1—multiple sclerosis	2.44e-05	0.000169	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.44e-05	0.000168	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.44e-05	0.000168	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ALB—multiple sclerosis	2.4e-05	0.000165	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.39e-05	0.000165	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.39e-05	0.000165	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.38e-05	0.000164	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—APOE—multiple sclerosis	2.36e-05	0.000163	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL2—multiple sclerosis	2.36e-05	0.000163	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TGFB1—multiple sclerosis	2.35e-05	0.000162	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—MAPK1—multiple sclerosis	2.31e-05	0.000159	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—APOE—multiple sclerosis	2.3e-05	0.000159	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.29e-05	0.000158	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL10—multiple sclerosis	2.28e-05	0.000158	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—BCHE—multiple sclerosis	2.26e-05	0.000156	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MMP9—multiple sclerosis	2.23e-05	0.000154	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.23e-05	0.000154	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.22e-05	0.000153	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.22e-05	0.000153	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.17e-05	0.00015	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.14e-05	0.000147	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—APOE—multiple sclerosis	2.11e-05	0.000145	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CD80—multiple sclerosis	2.08e-05	0.000144	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SRM—multiple sclerosis	2.08e-05	0.000143	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.07e-05	0.000143	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.03e-05	0.00014	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—POMC—multiple sclerosis	2.03e-05	0.00014	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CD86—multiple sclerosis	2e-05	0.000138	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—STAT3—multiple sclerosis	1.99e-05	0.000137	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—IL6—multiple sclerosis	1.98e-05	0.000137	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCL5—multiple sclerosis	1.97e-05	0.000136	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—APOE—multiple sclerosis	1.97e-05	0.000136	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.95e-05	0.000134	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.93e-05	0.000133	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.9e-05	0.000131	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.9e-05	0.000131	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.86e-05	0.000128	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ALB—multiple sclerosis	1.85e-05	0.000128	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.85e-05	0.000127	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MYC—multiple sclerosis	1.85e-05	0.000127	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TGFB1—multiple sclerosis	1.84e-05	0.000127	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—BCHE—multiple sclerosis	1.84e-05	0.000127	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SPP1—multiple sclerosis	1.82e-05	0.000126	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—POMC—multiple sclerosis	1.81e-05	0.000125	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MAPK1—multiple sclerosis	1.81e-05	0.000125	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCR5—multiple sclerosis	1.77e-05	0.000122	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TYK2—multiple sclerosis	1.76e-05	0.000121	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2RA—multiple sclerosis	1.75e-05	0.00012	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.74e-05	0.00012	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.74e-05	0.00012	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—APOE—multiple sclerosis	1.72e-05	0.000118	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—POMC—multiple sclerosis	1.69e-05	0.000116	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.68e-05	0.000116	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—APOE—multiple sclerosis	1.67e-05	0.000115	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ALB—multiple sclerosis	1.65e-05	0.000114	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—APOE—multiple sclerosis	1.61e-05	0.000111	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.61e-05	0.000111	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CD4—multiple sclerosis	1.59e-05	0.00011	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ALB—multiple sclerosis	1.54e-05	0.000106	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—POMC—multiple sclerosis	1.48e-05	0.000102	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.47e-05	0.000101	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.47e-05	0.000101	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CD80—multiple sclerosis	1.46e-05	0.0001	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.44e-05	9.93e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—POMC—multiple sclerosis	1.44e-05	9.9e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.43e-05	9.88e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.4e-05	9.68e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL6—multiple sclerosis	1.39e-05	9.57e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—POMC—multiple sclerosis	1.38e-05	9.55e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.38e-05	9.51e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.37e-05	9.46e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—APOE—multiple sclerosis	1.36e-05	9.37e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCL2—multiple sclerosis	1.35e-05	9.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ALB—multiple sclerosis	1.35e-05	9.28e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.34e-05	9.25e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ALB—multiple sclerosis	1.31e-05	9.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.31e-05	9.01e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.26e-05	8.67e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.23e-05	8.49e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—multiple sclerosis	1.23e-05	8.49e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TYK2—multiple sclerosis	1.23e-05	8.48e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—STAT3—multiple sclerosis	1.23e-05	8.48e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.19e-05	8.2e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—POMC—multiple sclerosis	1.17e-05	8.05e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—multiple sclerosis	1.14e-05	7.88e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFB1—multiple sclerosis	1.14e-05	7.86e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.12e-05	7.74e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.12e-05	7.74e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MAPK1—multiple sclerosis	1.12e-05	7.71e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.12e-05	7.7e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.11e-05	7.66e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—APOE—multiple sclerosis	1.11e-05	7.63e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ALB—multiple sclerosis	1.06e-05	7.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.06e-05	7.32e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—APOE—multiple sclerosis	1.05e-05	7.22e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2—multiple sclerosis	1.02e-05	7.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.02e-05	7.06e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MMP9—multiple sclerosis	9.69e-06	6.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—BCHE—multiple sclerosis	9.67e-06	6.67e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.59e-06	6.62e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—POMC—multiple sclerosis	9.51e-06	6.56e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—POMC—multiple sclerosis	8.99e-06	6.2e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.75e-06	6.03e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ALB—multiple sclerosis	8.67e-06	5.98e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT3—multiple sclerosis	8.61e-06	5.94e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—multiple sclerosis	8.59e-06	5.93e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—APOE—multiple sclerosis	8.45e-06	5.83e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—BCHE—multiple sclerosis	8.27e-06	5.7e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—APOE—multiple sclerosis	8.25e-06	5.69e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ALB—multiple sclerosis	8.2e-06	5.65e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—multiple sclerosis	8e-06	5.52e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFB1—multiple sclerosis	7.98e-06	5.51e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK1—multiple sclerosis	7.83e-06	5.4e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—POMC—multiple sclerosis	7.26e-06	5e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—APOE—multiple sclerosis	7.15e-06	4.93e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—POMC—multiple sclerosis	7.09e-06	4.89e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ALB—multiple sclerosis	6.61e-06	4.56e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ALB—multiple sclerosis	6.47e-06	4.46e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—APOE—multiple sclerosis	6.38e-06	4.4e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.38e-06	4.4e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—POMC—multiple sclerosis	6.14e-06	4.24e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—multiple sclerosis	6.02e-06	4.15e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APOE—multiple sclerosis	5.82e-06	4.01e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ALB—multiple sclerosis	5.6e-06	3.86e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—POMC—multiple sclerosis	5.48e-06	3.78e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—POMC—multiple sclerosis	5e-06	3.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ALB—multiple sclerosis	5e-06	3.45e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOE—multiple sclerosis	4.97e-06	3.43e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ALB—multiple sclerosis	4.56e-06	3.14e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—POMC—multiple sclerosis	4.27e-06	2.95e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ALB—multiple sclerosis	3.89e-06	2.69e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOE—multiple sclerosis	3.84e-06	2.65e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—POMC—multiple sclerosis	3.3e-06	2.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALB—multiple sclerosis	3.01e-06	2.07e-05	CbGpPWpGaD
